Pharmacist Interview Questions & Answers

Sample Answer

A patient came in with a new prescription for clarithromycin while already taking simvastatin. This combination carries a risk of severe rhabdomyolysis. I called the prescribing physician, explained the interaction with supporting evidence, and suggested an alternative antibiotic -- azithromycin, which doesn't have the same interaction profile. The physician agreed and changed the prescription. I documented the intervention in our clinical tracking system. This interaction was flagged by our software, but I've also caught interactions that the system missed, which is why pharmacist clinical judgment remains essential.

Sample Answer

During a staffing shortage, our district manager pushed to increase our daily fill rate from 350 to 450 prescriptions. I ran the numbers and presented data showing that our near-miss rate increased 3x when volume exceeded 380 with our current staffing. I proposed a compromise: hire one additional technician and implement a workflow redesign that could safely handle 420 prescriptions. We implemented the changes, and our error rate actually decreased while volume increased by 20%. Safety and efficiency aren't enemies -- you just can't optimize one by ignoring the other.

Sample Answer

An elderly patient was picking up three medications from different prescribers, and during a medication therapy management review, I noticed a therapeutic duplication -- two different brand-name ACE inhibitors prescribed by a cardiologist and a PCP. The patient was experiencing persistent hypotension and dizziness. I contacted both prescribers, coordinated the medication reconciliation, and the duplicate was discontinued. The patient's blood pressure stabilized and their dizziness resolved within a week. This case reinforced why MTM reviews are one of the most valuable clinical services a pharmacist provides.

Sample Answer

I noticed our technician team was making frequent data entry errors -- wrong quantities, wrong days' supply. Instead of disciplining, I analyzed the errors and found a pattern: 80% occurred with specific insurance plan overrides. I created a quick-reference guide with the 15 most common insurance scenarios and ran three 30-minute training sessions. Data entry errors dropped by 65% within 6 weeks. I also started a weekly 10-minute huddle where technicians could ask questions about difficult claims, which further reduced errors and built team confidence.

Sample Answer

I cover five essential areas. First, the purpose: warfarin prevents blood clots, and consistent dosing at the same time daily is critical. Second, monitoring: regular INR testing is mandatory, and I explain target ranges. Third, diet: maintain consistent vitamin K intake -- don't suddenly increase or decrease leafy green consumption. Fourth, drug interactions: avoid NSAIDs, many antibiotics, and numerous supplements without consulting the pharmacist. I specifically ask about aspirin and OTC pain relievers. Fifth, safety signs: seek emergency care for unusual bleeding, dark stools, blood in urine, or persistent headaches. I verify they understand the importance of not skipping doses and not doubling up if a dose is missed.

Sample Answer

First, I recount the physical inventory against the perpetual inventory record to confirm the discrepancy. If confirmed, I review all recent controlled substance transactions: prescriptions dispensed, returns to stock, and incoming orders for that specific drug. I check security camera footage if available. I document the discrepancy on DEA form 106 if it appears to be theft or loss. I report to the pharmacy manager, and if the discrepancy suggests diversion, we report to the state board of pharmacy and the DEA. I never alter records to make numbers match -- that compounds the problem. Prevention is better: I conduct daily controlled substance counts for Schedule II medications.

Sample Answer

I look for red flags: altered quantities or refill numbers, prescriptions from distant or unfamiliar prescribers, multiple controlled substance prescriptions from different doctors (doctor shopping), early refill requests, and cash payment for controlled substances when the patient has insurance. I check the Prescription Drug Monitoring Program (PDMP) to see the patient's fill history across pharmacies. I call the prescriber's office using the phone number I look up independently -- not the number on the prescription. If I can't verify the prescription's legitimacy, I have the legal authority and responsibility to refuse to fill it. I document my reasoning and report suspected fraud to the DEA.

Sample Answer

I review seven key areas: drug-drug interactions with the patient's current medication profile, drug-disease contraindications, appropriate dose for the patient's age, weight, and renal/hepatic function, therapeutic duplication, drug allergy cross-reactivity, appropriate duration of therapy, and potential for abuse or misuse of controlled substances. I also consider patient-specific factors like pregnancy status, lactation, and ability to swallow specific dosage forms. The automated DUR system catches many issues, but I manually review complex patients because software can't weigh clinical context the way a pharmacist can.

Sample Answer

I remain calm and professional -- I don't match their energy. I explain clearly that early refills for controlled substances are regulated by state law and their insurance, and that I'm legally unable to override these requirements. I empathize: 'I understand this is frustrating.' I check if there are legitimate reasons for early refill -- dose change, lost medication with a police report, travel. If none apply, I suggest they contact their prescriber for a bridge prescription if they're running out early. If the patient becomes threatening, I calmly end the interaction and call security or law enforcement. I document every interaction related to controlled substance disputes.

Sample Answer

I contact the patient immediately by phone. I calmly explain the situation and instruct them not to take the medication if they haven't already. If they've already taken it, I assess the clinical risk: what was dispensed versus what was prescribed, and whether the difference is clinically significant. If there's a risk of harm, I direct them to seek immediate medical attention or call poison control. I document the error thoroughly, notify the pharmacist-in-charge, complete an incident report, and conduct a root cause analysis to prevent recurrence. I also contact the prescriber to inform them. Transparency is essential -- covering up errors puts patients at risk and violates professional ethics.

Sample Answer

I have a professional obligation to refuse to fill a prescription I believe is harmful, regardless of prescriber insistence. I'd ask the prescriber to explain the clinical rationale for the dose -- maybe there's a context I'm missing, like the patient's weight, tolerance, or specific condition. If their explanation satisfies me clinically, I document the conversation and dispense. If it doesn't, I respectfully decline and explain my reasoning, citing specific references. I'd suggest the prescriber consult with a specialist or another pharmacist. I document everything. My license is on the line alongside theirs, and my primary obligation is to the patient's safety, not to the prescriber's preference.

Sample Answer

I triage the queue: urgent medications first (antibiotics for acute infections, pain management for post-surgical patients, insulin, cardiac medications), then maintenance refills. I communicate wait times honestly to patients -- false promises create more frustration than honest delays. I maximize technician efficiency by handling only pharmacist-required tasks myself: clinical reviews, counseling, and controlled substance verification. I call patients waiting for non-urgent refills to let them know about the delay and offer next-day pickup. If safety is compromised, I have the authority and obligation to temporarily reduce volume -- I'd rather fill fewer prescriptions correctly than many incorrectly.